445 related articles for article (PubMed ID: 25703627)
1. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis.
Syx D; Van Damme T; Symoens S; Maiburg MC; van de Laar I; Morton J; Suri M; Del Campo M; Hausser I; Hermanns-Lê T; De Paepe A; Malfait F
Hum Mutat; 2015 May; 36(5):535-47. PubMed ID: 25703627
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome.
Kosho T; Mizumoto S; Watanabe T; Yoshizawa T; Miyake N; Yamada S
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31905796
[TBL] [Abstract][Full Text] [Related]
3. Defect in dermatan sulfate in urine of patients with Ehlers-Danlos syndrome caused by a CHST14/D4ST1 deficiency.
Mizumoto S; Kosho T; Hatamochi A; Honda T; Yamaguchi T; Okamoto N; Miyake N; Yamada S; Sugahara K
Clin Biochem; 2017 Aug; 50(12):670-677. PubMed ID: 28238810
[TBL] [Abstract][Full Text] [Related]
4. Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome.
Müller T; Mizumoto S; Suresh I; Komatsu Y; Vodopiutz J; Dundar M; Straub V; Lingenhel A; Melmer A; Lechner S; Zschocke J; Sugahara K; Janecke AR
Hum Mol Genet; 2013 Sep; 22(18):3761-72. PubMed ID: 23704329
[TBL] [Abstract][Full Text] [Related]
5. CHST14/D4ST1 deficiency: New form of Ehlers-Danlos syndrome.
Kosho T
Pediatr Int; 2016 Feb; 58(2):88-99. PubMed ID: 26646600
[TBL] [Abstract][Full Text] [Related]
6. Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome.
Miyake N; Kosho T; Mizumoto S; Furuichi T; Hatamochi A; Nagashima Y; Arai E; Takahashi K; Kawamura R; Wakui K; Takahashi J; Kato H; Yasui H; Ishida T; Ohashi H; Nishimura G; Shiina M; Saitsu H; Tsurusaki Y; Doi H; Fukushima Y; Ikegawa S; Yamada S; Sugahara K; Matsumoto N
Hum Mutat; 2010 Aug; 31(8):966-74. PubMed ID: 20533528
[TBL] [Abstract][Full Text] [Related]
7. Structural alteration of glycosaminoglycan side chains and spatial disorganization of collagen networks in the skin of patients with mcEDS-CHST14.
Hirose T; Takahashi N; Tangkawattana P; Minaguchi J; Mizumoto S; Yamada S; Miyake N; Hayashi S; Hatamochi A; Nakayama J; Yamaguchi T; Hashimoto A; Nomura Y; Takehana K; Kosho T; Watanabe T
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):623-631. PubMed ID: 30553867
[TBL] [Abstract][Full Text] [Related]
8. The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.
Janecke AR; Li B; Boehm M; Krabichler B; Rohrbach M; Müller T; Fuchs I; Golas G; Katagiri Y; Ziegler SG; Gahl WA; Wilnai Y; Zoppi N; Geller HM; Giunta C; Slavotinek A; Steinmann B
Am J Med Genet A; 2016 Jan; 170A(1):103-15. PubMed ID: 26373698
[TBL] [Abstract][Full Text] [Related]
9. Musculocontractural Ehlers-Danlos syndrome and neurocristopathies: dermatan sulfate is required for Xenopus neural crest cells to migrate and adhere to fibronectin.
Gouignard N; Maccarana M; Strate I; von Stedingk K; Malmström A; Pera EM
Dis Model Mech; 2016 Jun; 9(6):607-20. PubMed ID: 27101845
[TBL] [Abstract][Full Text] [Related]
10. Mouse Models of Musculocontractural Ehlers-Danlos Syndrome.
Yoshizawa T; Kosho T
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833362
[TBL] [Abstract][Full Text] [Related]
11. Musculocontractural Ehlers-Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene.
Malfait F; Syx D; Vlummens P; Symoens S; Nampoothiri S; Hermanns-Lê T; Van Laer L; De Paepe A
Hum Mutat; 2010 Nov; 31(11):1233-9. PubMed ID: 20842734
[TBL] [Abstract][Full Text] [Related]
12. Histories of Dermatan Sulfate Epimerase and Dermatan 4-
Mizumoto S; Yamada S
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833436
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathophysiological delineation of musculocontractural Ehlers-Danlos syndrome caused by dermatan sulfate epimerase deficiency (mcEDS-DSE): A detailed and comprehensive glycobiological and pathological investigation in a novel patient.
Minatogawa M; Hirose T; Mizumoto S; Yamaguchi T; Nagae C; Taki M; Yamada S; Watanabe T; Kosho T
Hum Mutat; 2022 Dec; 43(12):1829-1836. PubMed ID: 35842784
[TBL] [Abstract][Full Text] [Related]
14. Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency.
Lautrup CK; Teik KW; Unzaki A; Mizumoto S; Syx D; Sin HH; Nielsen IK; Markholt S; Yamada S; Malfait F; Matsumoto N; Miyake N; Kosho T
Mol Genet Genomic Med; 2020 May; 8(5):e1197. PubMed ID: 32130795
[TBL] [Abstract][Full Text] [Related]
15. Dermatan sulfate epimerase 1 and dermatan 4-
Tykesson E; Hassinen A; Zielinska K; Thelin MA; Frati G; Ellervik U; Westergren-Thorsson G; Malmström A; Kellokumpu S; Maccarana M
J Biol Chem; 2018 Aug; 293(35):13725-13735. PubMed ID: 29976758
[TBL] [Abstract][Full Text] [Related]
16. Systematic investigation of the skin in Chst14-/- mice: A model for skin fragility in musculocontractural Ehlers-Danlos syndrome caused by CHST14 variants (mcEDS-CHST14).
Hirose T; Mizumoto S; Hashimoto A; Takahashi Y; Yoshizawa T; Nitahara-Kasahara Y; Takahashi N; Nakayama J; Takehana K; Okada T; Nomura Y; Yamada S; Kosho T; Watanabe T
Glycobiology; 2021 Feb; 31(2):137-150. PubMed ID: 32601684
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix and platelet function in patients with musculocontractural Ehlers-Danlos syndrome caused by mutations in the CHST14 gene.
Mendoza-Londono R; Chitayat D; Kahr WH; Hinek A; Blaser S; Dupuis L; Goh E; Badilla-Porras R; Howard A; Mittaz L; Superti-Furga A; Unger S; Nishimura G; Bonafe L
Am J Med Genet A; 2012 Jun; 158A(6):1344-54. PubMed ID: 22581468
[TBL] [Abstract][Full Text] [Related]
18. Vascular abnormalities in the placenta of Chst14-/- fetuses: implications in the pathophysiology of perinatal lethality of the murine model and vascular lesions in human CHST14/D4ST1 deficiency.
Yoshizawa T; Mizumoto S; Takahashi Y; Shimada S; Sugahara K; Nakayama J; Takeda S; Nomura Y; Nitahara-Kasahara Y; Okada T; Matsumoto K; Yamada S; Kosho T
Glycobiology; 2018 Feb; 28(2):80-89. PubMed ID: 29206923
[TBL] [Abstract][Full Text] [Related]
19. DSE associated musculocontractural EDS, a milder phenotype or phenotypic variability.
Schirwani S; Metcalfe K; Wagner B; Berry I; Sobey G; Jewell R
Eur J Med Genet; 2020 Apr; 63(4):103798. PubMed ID: 31655143
[TBL] [Abstract][Full Text] [Related]
20. Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes.
Syx D; Delbaere S; Bui C; De Clercq A; Larson G; Mizumoto S; Kosho T; Fournel-Gigleux S; Malfait F
Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1843-C1859. PubMed ID: 35993517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
